Additional file 1: of Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
- Biagio Ricciuti (6409355)
- Sasha Kravets (5545475)
- Suzanne Dahlberg (6525611)
- Renato Umeton (413065)
- Adem Albayrak (6525617)
- Safiya Subegdjo (6525620)
- Bruce Johnson (772564)
- Mizuki Nishino (6525623)
- Lynette Sholl (3564347)
- Mark Awad (6525626)
Publication date
March 2019
DOIAbstract
Figure S1. Diagram of patients with SCLC who underwent successful next generation sequencing who either did or did not receive treatment with immune checkpoint inhibitors. Patients who never received any systemic therapy for their disease are indicated. (DOCX 81 kb
Add to ORKG